The Latest
Historic Warning Signal Suggests the Stock Market Is Headed Somewhere Investors Do Not Want to Go

Historic Warning Signal Suggests the Stock Market Is Headed Somewhere Investors Do Not Want to Go

A historic warning signal suggests the stock market may be headed for a decline, prompting caution among investors. Details remain uncertain about timing and severity.
If a Stock Market Crash Is Coming, History Says Investors Who Do This 1 Thing Will Win Out

If a Stock Market Crash Is Coming, History Says Investors Who Do This 1 Thing Will Win Out

Historical data suggests that investors who adopt a specific strategy tend to outperform during stock market crashes. Here’s what you need to know.
S&P 500’s Sky-High CAPE Ratio Just Hit a Level Only Seen During the Dot-Com Bubble

S&P 500’s Sky-High CAPE Ratio Just Hit a Level Only Seen During the Dot-Com Bubble

The S&P 500’s cyclically adjusted price-to-earnings ratio has reached levels only seen during the late 1990s dot-com bubble, signaling potential overvaluation.
13 Best Financial Planning Software in 2026

13 Best Financial Planning Software in 2026

Discover the top financial planning software of 2026, including the best overall, value options, and beginner-friendly picks to help you achieve your financial goals.
12 Best Investment Tracking Tools in 2026

12 Best Investment Tracking Tools in 2026

Discover the top investment tracking tools of 2026. Find the best options for portfolios, beginners, and more to grow your investments with confidence.
Ascletis Submits Two IND Applications To The U.S. FDA For The Treatment Of Obesity: ASC36 Once-Monthly Injection, A Peptide Amylin Receptor Agonist, And ASC36_35 FDC Once-Monthly Injection, A Co-Formulation Of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

Ascletis Submits Two IND Applications To The U.S. FDA For The Treatment Of Obesity: ASC36 Once-Monthly Injection, A Peptide Amylin Receptor Agonist, And ASC36_35 FDC Once-Monthly Injection, A Co-Formulation Of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

Ascletis has filed two Investigational New Drug applications with the US FDA for new obesity treatments, including a peptide-based injection and a co-formulation.
Costerfield – True Blue Exploration Update

Costerfield – True Blue Exploration Update

Costerfield provides an update on its True Blue exploration project, confirming ongoing drilling results and future plans amid ongoing development.
Hyundai Motor Brings Atlas Humanoid Robot To FIFA World Cup 2026™ In First-Ever Live Match Environment Robotics Integration

Hyundai Motor Brings Atlas Humanoid Robot To FIFA World Cup 2026™ In First-Ever Live Match Environment Robotics Integration

Hyundai Motor introduces its Atlas humanoid robot into a live match environment at FIFA World Cup 2026™, marking the first-ever such integration.
Hikvision Erhält Branchenweit Erste EUCC-Zertifizierung Für Netzwerkkameras

Hikvision Erhält Branchenweit Erste EUCC-Zertifizierung Für Netzwerkkameras

Hikvision ist die erste Branche, die die EUCC-Zertifizierung für ihre Netzwerkkameras erhält, was neue Standards für Sicherheit und Compliance setzt.
BofA Technician Sees a ‘Three-Wave Correction’ in S&P 500 Index

BofA Technician Sees a ‘Three-Wave Correction’ in S&P 500 Index

Bank of America technician forecasts a ‘three-wave correction’ in the S&P 500 index, signaling potential near-term decline amid broader market uncertainty.